Keywords
Cephalosporins
Azithromycin
Pharmacological analysis
Submitted : 2025-06-02
Accepted : 2025-06-17
Published : 2025-07-02
Abstract
Objective: To analyze the efficacy of azithromycin combined with cephalosporins in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods: A total of 62 AECOPD patients who visited the hospital from January 2024 to December 2024 were selected as samples and randomly divided into two groups using the lottery method. Group A was treated with azithromycin and cephalosporins, while Group B was treated with cephalosporins only. The efficacy, lung function, inflammatory factors, and adverse reactions were compared between the two groups. Results: The efficacy of AECOPD treatment in Group A was higher than that in Group B (P < 0.05). The forced vital capacity (FVC), peak expiratory flow (PEF), and forced expiratory volume in 1 second (FEV1) in Group A were all higher than those in Group B (P < 0.05). The levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α) in Group A were all lower than those in Group B (P < 0.05). Conclusion: The combination of azithromycin and cephalosporins in the treatment of AECOPD can inhibit inflammatory factors and improve lung function, with safety and high efficiency.
References
Zhao D, 2022, Exploring the Clinical Efficacy and Safety of Azithromycin Combined with Cephalosporins in the Treatment of AECOPD. Contemporary Medicine, 28(6): 111–113.
Tong C, 2020, Guidelines for Clinical Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease in Elderly Chinese Patients. Chinese Journal of Tuberculosis and Respiratory Diseases, 43(2): 100–119.
Chen C, 2022, Analysis of the Efficacy of Azithromycin Combined with Ceftazidime in the Anti-Infection Treatment of AECOPD During Acute Exacerbation. Women’s Health Research, 2022(8): 16–17 + 20.
Zeng J, Yu Q, 2024, Efficacy of Azithromycin Combined with Cephalosporins in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Jilin Medical Journal, 45(1): 141–144.
Zhao B, 2021, Efficacy of Azithromycin Combined with Cephalosporins in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Impact on IgG Antibodies and Lung Function in Patients. Journal of Clinical Rational Drug Use, 14(2): 66–68.
Jiang J, 2021, Observation on the Efficacy of Azithromycin Combined with Cephalosporins in the Anti-Infection Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Contemporary Medicine, 27(1): 15–17.
Deng J, 2020, Safety and Impact on Lung Function of Cefaclor Combined with Azithromycin in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Contemporary Medical Forum, 18(17): 134–135.
Liu P, 2020, Clinical Efficacy of Ceftazidime Sodium Combined with Azithromycin in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Impact on Lung Function. Anti-infection Pharmacy, 17(2): 302–304.
You Y, 2023, Analysis of the Efficacy of Azithromycin Combined with Cephalosporins in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Chinese Journal of Modern Drug Application, 17(7): 86–88.
Fang Y, 2020, Analysis of the Efficacy of Azithromycin Combined with Cephalosporins in the Anti-Infection Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Northern Pharmacy, 17(1): 28–29.